跳至主要内容
临床试验/NCT01278732
NCT01278732已完成不适用

Central Blood Pressure Over 24 Hours (ABPM) and Left Ventricular Mas

Klinikum Wels-Grieskirchen10 个研究点 分布在 7 个国家目标入组 350 人开始时间: 2011年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
350
试验地点
10
主要终点
Left ventricular mass (m-mode echocardiography)

研究概览

简要总结

The investigators aim to investigate whether central systolic blood pressure, as measured during regular 24 hour ambulatory blood pressure monitoring (ABPM), is a better predictor of left ventricular mass than peripheral systolic blood pressure during ABPM.

详细描述

It seems obvious that central blood pressures are pathophysiologically more relevant than peripheral blood pressures for the pathogenesis of cardiovascular disease: it is central systolic pressure (cSBP) against the heart ejects (afterload), and it is central pulse pressure (cPP) that distends the large elastic arteries. Indeed, cSBP and cPP have been associated more closely with left ventricular hypertrophy and carotid atherosclerosis as markers of hypertensive end-organ damage than brachial pressures in various populations. However, in these studies office blood pressure measurements have been used. As ABPM measurements per se show a closer association with hypertensive end-organ damage than office measurements, and as the investigators have recently developed and validated a novel algorithm (ARCSolver) to calculate central blood pressures from peripheral waveforms, the investigators speculate that cSBP measured during ABPM may be the best predictor of left ventricular mass.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • > 18 years of age,
  • no intake of antihypertensive medications
  • should have an indication for ABPM (suspected arterial hypertension)

排除标准

  • no written informed consent
  • left ventricular hypertrophy due to other reasons than hypertension (hypertrophic cardiomyopathy, infiltrative cardiomyopathy, valvular heart disease, congenital heart disease)
  • inability to provide adequate echocardiographic readings
  • segmental contraction abnormalities of the left ventricle
  • contraindications for ABPM (lymphedema both arms)
  • other rhythm than stable sinus rhythm
  • unstable clinical condition, including recent severe infections

结局指标

主要结局

Left ventricular mass (m-mode echocardiography)

时间窗: measured within 4 weeks from ABPM

次要结局

  • urine albumine / creatinine ratio(measured within 2 weeks from ABPM but before antihypertensive treatment is started)

研究者

发起方
Klinikum Wels-Grieskirchen
申办方类型
Other
责任方
Principal Investigator
主要研究者

Thomas Weber

PD Dr. Thomas Weber

Klinikum Wels-Grieskirchen

研究点 (10)

Loading locations...

相似试验